GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Price-to-Free-Cash-Flow

PharmaTher Holdings (XCNQ:PHRM) Price-to-Free-Cash-Flow : N/A (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Price-to-Free-Cash-Flow?

As of today (2024-06-05), PharmaTher Holdings's share price is C$0.22. PharmaTher Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.04. Hence, PharmaTher Holdings's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for PharmaTher Holdings's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 3 years, PharmaTher Holdings's highest Price-to-Free-Cash-Flow Ratio was 70.00. The lowest was 0.00. And the median was 0.00.

XCNQ:PHRM's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 30.345
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

PharmaTher Holdings's Free Cash Flow per Share for the three months ended in Feb. 2024 was C$-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was C$-0.04.


PharmaTher Holdings Price-to-Free-Cash-Flow Historical Data

The historical data trend for PharmaTher Holdings's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Price-to-Free-Cash-Flow Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Price-to-Free-Cash-Flow
21.54 - -

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PharmaTher Holdings's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, PharmaTher Holdings's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaTher Holdings's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's Price-to-Free-Cash-Flow falls into.



PharmaTher Holdings Price-to-Free-Cash-Flow Calculation

PharmaTher Holdings's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.22/-0.044
=N/A

PharmaTher Holdings's Share Price of today is C$0.22.
PharmaTher Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

PharmaTher Holdings  (XCNQ:PHRM) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


PharmaTher Holdings Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings (XCNQ:PHRM) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines